Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Clinical and histopathological tumour progression in ECL cell carcinoids ("ECLomas").

Qvigstad G, Falkmer S, Westre B, Waldum HL.

APMIS. 1999 Dec;107(12):1085-92.

PMID:
10660138
2.

Spontaneous ECLomas in cotton rats (Sigmodon hispidus): tumours occurring in hypoacidic/hypergastrinaemic animals with normal parietal cells.

Cui G, Qvigstad G, Falkmer S, Sandvik AK, Kawase S, Waldum HL.

Carcinogenesis. 2000 Jan;21(1):23-7.

PMID:
10607729
3.

Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.

Linder S, Myrvold K, Falkmer UG, Qvigstad G, Waldum HL, Falkmer SE.

J Exp Clin Cancer Res. 2006 Jun;25(2):213-21.

PMID:
16918133
4.

Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.

Qvigstad G, Qvigstad T, Westre B, Sandvik AK, Brenna E, Waldum HL.

APMIS. 2002 Feb;110(2):132-9.

PMID:
12064868
5.

Hypergastrinemia and gastric enterochromaffin-like cells.

Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P.

Am J Surg Pathol. 1995;19 Suppl 1:S8-19. Review.

PMID:
7762739
6.

Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique.

Qvigstad G, Sandvik AK, Brenna E, Aase S, Waldum HL.

Histochem J. 2000 Sep;32(9):551-6.

PMID:
11127976
7.

Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia.

Higham AD, Bishop LA, Dimaline R, Blackmore CG, Dobbins AC, Varro A, Thompson DG, Dockray GJ.

Gastroenterology. 1999 Jun;116(6):1310-8.

PMID:
10348814
8.

Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin.

Bordi C, Falchetti A, Buffa R, Azzoni C, D'Adda T, Caruana P, Rindi G, Brandi ML.

Hum Pathol. 1994 Feb;25(2):175-80.

PMID:
8119718
9.

Treatment of ECL cell carcinoids with octreotide LAR.

Fykse V, Sandvik AK, Qvigstad G, Falkmer SE, Syversen U, Waldum HL.

Scand J Gastroenterol. 2004 Jul;39(7):621-8.

PMID:
15370681
10.

Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.

Kölby L, Wängberg B, Ahlman H, Modlin IM, Theodorsson E, Nilsson O.

Regul Pept. 1999 Dec 23;85(2-3):115-23.

PMID:
10651065
11.

Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells.

Srivastava A, Kamath A, Barry SA, Dayal Y.

Endocr Pathol. 2004 Spring;15(1):47-54.

PMID:
15067176
12.

Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.

Azzoni C, Doglioni C, Viale G, Delle Fave G, De Boni M, Caruana P, Ferraro G, Bordi C.

Am J Surg Pathol. 1996 Apr;20(4):433-41.

PMID:
8604810
13.

Ultrastructure and chromogranin A immunogold labelling of ECL cell carcinoids.

Fossmark R, Martinsen TC, Qvigstad G, Bendheim MØ, Kopstad G, Kashima K, Waldum HL.

APMIS. 2005 Jul-Aug;113(7-8):506-12.

PMID:
16086820
14.

Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats.

Håkanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F.

Gastroenterology. 1993 Jul;105(1):15-21.

PMID:
8514032
15.

Histamine as an intermediate growth factor in genesis of gastric ECLomas associated with hypergastrinemia in mastomys.

Modlin IM, Kumar RR, Soroka CJ, Ahlman H, Nilsson O, Goldenring JR.

Dig Dis Sci. 1994 Jul;39(7):1446-53.

PMID:
8026255
16.
17.

Gastric carcinoids of argyrophil ECL cells.

Capella C, Polak JM, Timson CM, Frigerio B, Solcia E.

Ultrastruct Pathol. 1980 Jul-Sep;1(3):411-8.

PMID:
7233595
18.

The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys.

Tang LH, Modlin IM, Lawton GP, Kidd M, Chinery R.

Gastroenterology. 1996 Nov;111(5):1212-23.

PMID:
8898635
19.

Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis.

Borch K, Stridsberg M, Burman P, Rehfeld JF.

Scand J Gastroenterol. 1997 Mar;32(3):198-202.

PMID:
9085454
20.

Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid.

Annibale B, Azzoni C, Corleto VD, di Giulio E, Caruana P, D'Ambra G, Bordi C, Delle Fave G.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1449-56.

PMID:
11742193

Supplemental Content

Support Center